Insulinomul pancreatic. Diagnostic și tratament

Autori

Cuvinte cheie:

insulinom pancreatic, diagnostic, tratament

Rezumat

În perioada 1993 - 2021 în cadrul Catedrei Chirurgie nr.2, IMSP SCR „Timofei Moşneaga” au fost internați şi operați 15 pacienţi, cu vârsta medie 47 ani (limitele absolute 36-73 ani), cu diagnosticul de tumoare neuroendocrină pancreatică (TNEP) „Insulinom pancreatic”. Diagnosticul a fost stabilit tardiv, datorită simptomatologiei neurologice severe, care a condus la adresări şi internări anterioare în serviciile de neurologie, psihiatrie şi endocrinologie. Simptomatologia insulinomului pancreatic a fost predominată de simptomele neuroglicopenice, adrenergice şi digestive. Diagnosticul de laborator a suspectat prezența tumorii prin intermediul aprecierii nivelului glucozei serice scăzute, creşterea insulinei serice şi peptidului C. Localizarea tumorii a fost stabilită prin următoarele metode imagistice: USG abdominală, CT în regim standard şi angiografic, RMN. Intervenţiile chirurgicale efectuate au fost: pancreatectomie corporo – caudală cu prezervarea splinei 5(33,33%) cazuri, pancreatectomie corporo – caudală fără prezervarea splinei - 4(26,67%) cazuri şi enuclearea tumorii – 6 (40,0%) cazuri. Diagnosticul de insulinom pancreatic a fost confirmat postoperator în toate cazurile prin efectuarea examenului histopatologic al țesuturilor rezecate.

Referințe

1. Baudin, E, Caron, P, Lombard-Bohas, C, et al. Malignant insulinoma: Recommendations for characterisation and treatment. Annales d'Endocrinologie. 1 decembrie 2013. Vol. 74, no. 5-6, p. 523-533. https://doi.org/10.1016/j.ando.2013.07.001

2. Berelavichus, S V., Kriger, AG, Dugarova, RS, Kaldarov, AR. Treatment of Insulinomas with Minimally Invasive Physical Procedure. Literature Review. SN Comprehensive Clinical Medicine. 2019. Vol. 1, no. 2. https://doi.org/10.1007/s42399-018-0024-5

3. Berger, HG, Warshaw, AL, Hruban, RH, et al. The pancreas. An integratedntextbook of basic science, medicine and surgery. Third edit. Oxford : Wiley Blackwell, 2018. ISBN 9781119188391. https://doi.org/10.1002/9781119188421

4. Boyko, V, Smachylo, R, Chernyayev, M, et al. Surgical treatment of insulinoma. Problemi Endokrinnoi Patologii. 2020. No. 4. DOI 10.21856/j-PEP.2020.4.02.

5. Brown, E, Watkin, D, Evans, J, et al. Multidisciplinary management of refractory insulinomas. Clinical Endocrinology. 1 mai 2018. Vol. 88, no. 5, p. 615-624. https://doi.org/10.1111/cen.13528

6. Duconseil, P, Marchese, U, Ewald, J, et al. A pancreatic zone at higher risk of fistula after enucleation. World Journal of Surgical Oncology. 29 august 2018. Vol. 16, no. 1, p. 1-9. https://doi.org/10.1186/s12957-018-1476-5

7. Falconi, M, Eriksson, B, Kaltsas, G, et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 1 aprilie 2016. Vol. 103, no. 2, p. 153-171. https://doi.org/10.1159/000443171

8. Fidler, JL, Fletcher, JG, Reading, CC, et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. 2003. https://doi.org/10.2214/ajr.181.3.1810775

9. Fu, J, Zhang, J, Wang, Y, et al. Comparison of angio-CT versus multidetector CT in the detection and location for insulinomas. Clinical Radiology. 2020. Vol. 75, no. 10. https://doi.org/10.1016/j.crad.2020.05.012

10. Giannis, D, Moris, D, Karachaliou, GS, et al. Insulinomas: From diagnosis to treatment. A review of the literature. 2020.

11. Gregg, EW. The nuclear option for insulinomas. THE LANCET Diabetes & Endocrinology. 2013. Vol. 1, p. 82-84. https://doi.org/10.1016/S2213-8587(13)70060-3

12. Harada, K, Hanayama, Y, Hasegawa, K, et al. Paroxysmal hypertension induced by an insulinoma. Internal Medicine. 2017. Vol. 56, no. 4, p. 413-417. https://doi.org/10.2169/internalmedicine.56.7758

13. Hotineanu, A, Cazac, A, Ivancov, G, et al. Experienta catedrei chirurgie nr. 2 în diagnosticul şi tratamen tul chirurgical al insulinomului pancreatic. Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale. 2020. Vol. nr. 4(68), no. ISSN 1857-0011, p. 154-163.

14. Jensen RT, Berna MJ, Bingham DB, NJ. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer. 2008. Vol. 113, p. 1807‐1843. https://doi.org/10.1002/cncr.23648

15. Luo, Y, Pan, Q, Yao, S, et al. Glucagon-Like Peptide-1 Receptor PET/CT with 68 Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study. J Nucl Med. 2016. Vol. 57, p. 715-720. https://doi.org/10.2967/jnumed.115.167445

16. Maggio, I, Mollica, V, Brighi, N, et al. The functioning side of the pancreas: a review on insulinomas. 2020. https://doi.org/10.1007/s40618-019-01091-w

17. Mehrabi, A, Fischer, L, Hafezi, M, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. 2014. https://doi.org/10.1097/MPA.0000000000000110

18. Metz, DC, Jensen, RT. Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors. Gastroenterology. 2008. Vol. 135, no. 5, p. 1469-1492. https://doi.org/10.1053/j.gastro.2008.05.047

19. Mihai, BM, Lăcătuşu, CM, Arhire, LI, et al. Pathological aspects underlying pancreatogenous hyperinsulinemic hypoglycemia--report of three cases. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 2015. Vol. 56, no. 1, p. 251-256.

20. Nana, KE, Adrian, V. MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia. European Journal of Endocrinology. 2017. Vol. 117, no. 1, p. R37-R47. https://doi.org/10.1530/EJE-16-1062

21. Nockel, P, Babic, B, Millo, C, et al. Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan. The Journal of Clinical Endocrinology and Metabolism. 1 ianuarie 2017. Vol. 102, no. 1, p. 195. https://doi.org/10.1210/jc.2016-3445

22. Öberg, K. Pancreatic Endocrine Tumors. Seminars in Oncology. 1 decembrie 2010. Vol. 37, no. 6, p. 594-618.

https://doi.org/10.1053/j.seminoncol.2010.10.014

23. Partelli, S, Bartsch, DK, Capdevila, J, et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocri nology. 1 septembrie 2017. Vol. 105, no. 3, p. 255-265. https://doi.org/10.1159/000464292

24. Rouland, A, Bouillet, B, Legris, P, et al. Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion. Clinical Pharmacology : Advances and Applications. 2021. Vol. 13, p. 33. https://doi.org/10.2147/CPAA.S278978

25. Siddiqui, M, Vora, A, Ali, S, et al. Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia. Journal of the Endocrine Society. 2021. Vol. 5, no. 1. https://doi.org/10.1210/jendso/bvaa171

26. Spiro, AJ, Shakir, MKM, Hoang, TD. Successful LongTerm Medical Management of Unresectable Insulinomas. Case Reports in Oncology. 2020. Vol. 13, no. 2. https://doi.org/10.1159/000508996

27. Taneja, C, Groff, AJ, Lam, ML. Endoscopic Ethanol Ablation as Definitive Therapy for Suspected Insulinoma. Journal of the Endocrine Society. 2021. Vol. 5, no. Sup plement_1. https://doi.org/10.1210/jendso/bvab048.774

28. Thompson, SM, Vella, A, Service, FJ, et al. Impact of variant pancreatic arterial anatomy and overlap in regional perfusion on the interpretation of selective arterial calcium stimulation with hepatic venous sampling for preoperative localization of occult insulinoma. Surgery. 1 iulie 2015. Vol. 158, no. 1, p. 162-172. https://doi.org/10.1016/j.surg.2015.03.004

29. Thompson, SM, Vella, A, Thompson, GB, et al. Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis. J Clin Endocrinol Metab. 2015. Vol. 100, no. 11, p. 4189-4197. https://doi.org/10.1210/jc.2015-2404

30. Toaiari, M, Davì, M V., Dalle Carbonare, L, et al. Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas. Journal of Endocrinological Investigation 2013 36:9. 18 aprilie 2013. Vol. 36, no. 9, p. 753-758. DOI 10.3275/8942.

31. Tomky, D. Detection, Prevention, and Treatment of Hypoglycemia in the Hospital. Diabetes Spectrum. 1 ianuarie 2005. Vol. 18, no. 1, p. 39 LP - 44. https://doi.org/10.2337/diaspect.18.1.39

32. Torimoto, K, Okada, Y, Tanaka, Y, et al. Usefulness of hemoglobin a1c and glycated albumin measurements for insulinoma screening: An observational casecontrol study. BMC Cancer. 26 februarie 2019. Vol. 19, no. 1. https://doi.org/10.1186/s12885-019-5389-7

33. Tovazzi, V, Ferrari, VD, Berruti, A. Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome. 2021. https://doi.org/10.1007/s12020-020-02604-x

34. Whipple, AO, Frantz, VK. ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW. Annals of surgery. iunie 1935. Vol. 101, no. 6, p. 1299-1335. https://doi.org/10.1097/00000658-193506000-00001

35. Woo, C-Y, Jeong, JY, Jang, JE, et al. Clinical Features and Causes of Endogenous Hyperinsulinemic Hypoglycemia in Korea. dmj. 9 martie 2015. Vol. 39, no. 2, https://doi.org/10.4093/dmj.2015.39.2.126

36. Wu, M, Wang, H, Zhang, X, et al. p. 126-131. DOI 10.4093/dmj.2015.39.2.126. Efficacy of laparoscopic ultrasonography in laparoscopic resection of insulinoma. 1 mai 2017. Spring Media.

37. Yachida, S, Vakiani, E, White, CM, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. The American journal of surgical pathology. februarie 2012. Vol. 36, no. 2, p. 173-184. https://doi.org/10.1097/PAS.0b013e3182417d36

38. Yukina, MY, Nuralieva, NF, Troshina, EA, et al. The hypoglycemic syndrome (insulinoma): pathogenesis, etiology, laboratory diagnosis (review, part 1). Problems of Endocrinology. 19 septembrie 2017. Vol. 63, no. 4, p. 245-256. https://doi.org/10.14341/probl2017634245-256

39. Zandee, WT, De Herder, WW. Insulinoma. In : Encyclopedia of Endocrine Diseases. Elsevier, 2018. p. 58-62. ISBN 9780128122006.

https://doi.org/10.1016/B978-0-12-801238-3.65228-5

40. Zhang, J, Francois, R, Iyer, R, et al. Current Understanding of the Molecular Biology of Pancreatic Neuroendocrine Tumors. JNCI: Journal of the National Cancer Institute. 17 iulie 2013. Vol. 105, no. 14, p. 1005-1017. https://doi.org/10.1093/jnci/djt135

41. Dravecka I, Lazurova I. Nesidioblastosis in adults. Neo plasma. 2014;61(3):252-6. PMID: 24645840. https://doi.org/10.4149/neo_2014_047

Descărcări

Publicat

25.04.2026

Număr

Nr. 2(93) (2022): Supliment. Zilele Medicale ale Spitalului Clinic Municipal „Sfântul Arhanghel Mihail”

Secțiune

Articole

Licență

Creative Commons License

Această lucrare este licențiată în temeiul Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Cum cităm

[1]
Hotineanu, A. et al. 2026. Insulinomul pancreatic. Diagnostic și tratament. Sănătate Publică, Economie şi Management în Medicină. 2(93) (Apr. 2026), 62–71.

Articole similare

41-50 of 162

Puteți, de asemenea, începeți o căutare avansată de similaritate pentru acest articol.